We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
+7.8%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$38.8B
AUM Growth
+$2.96B
(+8.3%)
Cap. Flow
+$1.14B
Cap. Flow
% of AUM
2.93%
Top 10 Holdings %
Top 10 Hldgs %
12.28%
Holding
2,861
New
368
Increased
965
Reduced
1,202
Closed
293
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$401M |
| 2 |
Netflix
NFLX
|
+$388M |
| 3 |
Ford
F
|
+$340M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$330M |
| 5 |
Boeing
BA
|
+$329M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$391M |
| 2 |
TSMC
TSM
|
+$387M |
| 3 |
Oracle
ORCL
|
+$282M |
| 4 |
Advanced Micro Devices
AMD
|
+$248M |
| 5 |
Microsoft
MSFT
|
+$247M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.93% |
| 2 | Healthcare | 17.44% |
| 3 | Industrials | 12.95% |
| 4 | Consumer Discretionary | 11.52% |
| 5 | Financials | 10.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LUNA
2376
DELISTED
Luna Innovations Incorporated
LUNA
| $104K | ﹤0.01% |
14,500
-20,700
| -59% | -$183K |
|
2377
Kodak
KODK
$814M
| $103K | ﹤0.01% |
+25,200
| New | +$91K |
|
2378
908 Devices
MASS
$308M
| $103K | ﹤0.01% |
12,000
-16,900
| -58% | -$151K |
|
|
SACH
2379
Sachem Capital Corp
SACH
$39.6M
| $103K | ﹤0.01% |
27,700
-101,500
| -79% | -$373K |
|
2380
Recursion Pharmaceuticals
RXRX
$1.61B
| $103K | ﹤0.01% |
+15,400
| New | +$122K |
|
|
ONCT
2381
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $102K | ﹤0.01% |
6,485
-4,270
| -40% | -$84K |
|
2382
Riverview Bancorp
RVSB
$109M
| $101K | ﹤0.01% |
19,000
| – | – |
|
2383
Clarus
CLAR
$127M
| $101K | ﹤0.01% |
10,700
-14,800
| -58% | -$139K |
|
2384
Goldgroup Mining Inc.
GORO
$149M
| $101K | ﹤0.01% |
96,300
-16,900
| -15% | -$21.6K |
|
2385
Lineage Cell Therapeutics
LCTX
$262M
| $101K | ﹤0.01% |
67,099
-22,064
| -25% | -$30.8K |
|
2386
Protara Therapeutics
TARA
$220M
| $99K | ﹤0.01% |
31,618
-15,600
| -33% | -$51.6K |
|
2387
BioRestorative Therapies
BRTX
$6.62M
| $98.9K | ﹤0.01% |
+29,100
| New | +$89.3K |
|
2388
Century Therapeutics
IPSC
$372M
| $97.5K | ﹤0.01% |
+28,100
| New | +$123K |
|
2389
LG Display
LPL
$2.88B
| $95.7K | ﹤0.01% |
15,000
-500
| -3% | -$2.84K |
|
2390
Heron Therapeutics
HRTX
$92.7M
| $95K | ﹤0.01% |
62,900
-17,900
| -22% | -$44.8K |
|
2391
Vuzix
VUZI
$180M
| $94K | ﹤0.01% |
22,700
+5,900
| +35% | +$26.5K |
|
2392
Motorcar Parts of America
MPAA
$267M
| $93.7K | ﹤0.01% |
12,600
+100
| +0.8% | +$1.19K |
|
2393
Babcock & Wilcox
BW
$1.29B
| $92.9K | ﹤0.01% |
15,334
-41,893
| -73% | -$258K |
|
|
ICAD
2394
DELISTED
iCAD Inc
ICAD
| $92.1K | ﹤0.01% |
74,300
-41,300
| -36% | -$85.8K |
|
|
FLNT
2395
Fluent
FLNT
$108M
| $91.8K | ﹤0.01% |
18,650
-2,333
| -11% | -$18.2K |
|
2396
PureCycle Technologies
PCT
$1.23B
| $91.7K | ﹤0.01% |
+13,100
| New | +$91.3K |
|
2397
Hycroft Mining Holding Corp
HYMC
$1.81B
| $88.8K | ﹤0.01% |
20,530
-110
| -0.5% | -$536 |
|
2398
iHeartMedia
IHRT
$534M
| $88.5K | ﹤0.01% |
+22,700
| New | +$145K |
|
|
JNCE
2399
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $88.4K | ﹤0.01% |
47,800
-332,700
| -87% | -$412K |
|
|
SYBX
2400
DELISTED
Synlogic
SYBX
| $84.3K | ﹤0.01% |
8,893
-554
| -6% | -$6.58K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q1 2023 Portfolio in Review
As of Q1 2023, Two Sigma Advisers held 2,861 positions worth $38.8B, up 8.3% from $35.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Two Sigma Advisers's Q1 2023 filing shows 368 new, 965 increased, 1,202 reduced and 293 closed positions. Its largest new stake was Netflix: 11,730,000 shares worth $405M. The largest sale was Tesla, an estimated $391M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 25% a quarter earlier, followed by Healthcare and Industrials.
- Two Sigma Advisers's largest Q1 2023 buy was Netflix: 11,730,000 shares worth $405M.
- Two Sigma Advisers added most to CVS Health in Q1 2023, an estimated $401M increase.
- Two Sigma Advisers's biggest Q1 2023 reduction was TSMC, cutting an estimated $387M.
- Two Sigma Advisers fully exited Tesla in Q1 2023, selling an estimated $391M.
- Two Sigma Advisers's ten largest holdings make up 12% of its $38.8B portfolio in Q1 2023.
- Two Sigma Advisers opened 368 new positions and closed 293 in Q1 2023.
- Two Sigma Advisers's portfolio value rose 8.3% quarter-over-quarter to $38.8B.
Based on Two Sigma Advisers's 13F filing for Q1 2023, filed 15 May 2023.